Pradeep Thapar, MD
Psychiatry · Orland Park, ILNPI 1891889812
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,255 of the $75,569 with a category attached, or 77.1%. AbbVie accounts for 70.8% of it on its own, with 36 other manufacturers making up the rest. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 858 payments — averaging $88.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$54K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$8K
- Supernus Pharmaceuticals, Inc.$3K
- Lundbeck LLC$1K
- Johnson & Johnson$1K
- Otsuka America Pharmaceutical, Inc.$1K
- plus $8K from 31 others
What the payments were for
- Speaking & faculty fees$58,25577%
- Travel & lodging$1940%
- Food & beverage$17,06823%
- Education$520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$49,389
- CAPLYTA$6,842
- SPRAVATO$130
- Dyanavel XR$106
How this compares
$75,569 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 13 | $51,361 |
| VraylarCariprazine Hcl | 30 | $46,816 |
| RexultiBrexpiprazole | 15 | $29,933 |
| Vilazodone Hcl | 29 | $3,392 |
| Aripiprazole | 31 | $2,240 |
| Trazodone Hcl | 166 | $1,886 |
| Oxcarbazepine | 41 | $1,493 |
| Escitalopram Oxalate | 133 | $1,361 |
| Duloxetine Hcl | 128 | $1,232 |
| Bupropion XlBupropion Hcl | 64 | $1,228 |
| Hydroxyzine Hcl | 55 | $1,143 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 19 | $854 |
| Mirtazapine | 104 | $845 |
| Buspirone Hcl | 38 | $575 |
| Clonazepam | 71 | $551 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $1,150 | $51,36113 claims |
| AbbVieVraylar | $53,521 | $46,81630 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,150 | $29,93315 claims |
| Almatica Pharma LLCSertraline Hcl | $182 | $39638 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Orland Park
- Roukan JazayerliOrland Park$597K
- Nitin ThaparOrland Park$216K
- Rian RowlesOrland Park$15K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.